- Trials with a EudraCT protocol (113)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
113 result(s) found for: Fertilization.
Displaying page 2 of 6.
| EudraCT Number: 2013-002027-42 | Sponsor Protocol Number: POR-ELONVA | Start Date*: 2013-08-14 |
| Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
| Full Title: PROSPECTIVE AND RANDOMIZED STUDY FOR ASSESSMENT OF CONTROLLED OVARIAN STIMULATION WITH ALFA Corifollitropin IN PATIENTS WITH OVARIAN RESPONSE EXPECTED OR POOR IN VITRO FERTILIZATION CYCLE. | ||
| Medical condition: Women who meet the criteria for infertility Bologna | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000382-41 | Sponsor Protocol Number: PFL2021 | Start Date*: 2022-10-05 |
| Sponsor Name:Reproducción Bilbao. Ginegorama S.L. | ||
| Full Title: Protection of the luteal phase by means of progesterone in assisted reproduction procedures. Comparison of different routes of administration and study of predictive parameters of reproductive succ... | ||
| Medical condition: In this project, we propose the performance of a comparative study of different patterns of gestagenic coverage in in vitro fertilization (IVF) cycles with deferred transfer of genetically selected... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012121-11 | Sponsor Protocol Number: P06060 (299001) | Start Date*: 2009-10-13 | |||||||||||
| Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
| Full Title: A randomized, multicenter, explorative trial to explore the safety, acceptability and vaginal bleeding pattern of three doses of an etonogestrel-releasing medicated intrauterine system (ENG-MIUS) v... | |||||||||||||
| Medical condition: healthy parous women in need of contraception | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-000201-84 | Sponsor Protocol Number: AT2020_01 | Start Date*: 2020-04-07 |
| Sponsor Name:Das Kinderwunsch Institut Schenk GmbH | ||
| Full Title: Oral and intravenous iron substitution for the treatment of iron deficiency symptoms in the context of fertility treatment - an exploratory pilot study | ||
| Medical condition: infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-001503-36 | Sponsor Protocol Number: PROT25186 | Start Date*: 2004-11-03 | |||||||||||
| Sponsor Name:SERONO ESPAÑA, S.A. | |||||||||||||
| Full Title: Lutropin alfa (Luveris) in mid follicular phase for controlled ovarian stimulation (COS) in ovarian ageing: a randomised, comparative with parallel control group, phase II clinical trial. | |||||||||||||
| Medical condition: Controlled ovarian stimulation in women with ovarian ageing PT: Assisted Fertilisation | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-002678-10 | Sponsor Protocol Number: GF22002 | Start Date*: 2023-03-07 |
| Sponsor Name:Ginefiv | ||
| Full Title: Protocol with progestin-primed ovarian stimulation (PPOS) starting on day 5 versus protocol with progestin-primed ovarian stimulation (PPOS) in a conventional regimen from the start of the ovaria... | ||
| Medical condition: Number of MII oocytes obtained in both groups | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002936-17 | Sponsor Protocol Number: LIV001 | Start Date*: 2019-02-22 |
| Sponsor Name:Livio Falun | ||
| Full Title: Treatment with intralipid in assisted fertilization | ||
| Medical condition: Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005552-38 | Sponsor Protocol Number: ProFET | Start Date*: 2021-01-27 |
| Sponsor Name:Västragötalandsregionen, Sahlgrenska Universitetssjukhuset | ||
| Full Title: Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial | ||
| Medical condition: infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Trial now transitioned) IS (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-003980-74 | Sponsor Protocol Number: BAY1007626/15731 | Start Date*: 2015-06-17 | |||||||||||
| Sponsor Name:Bayer AG | |||||||||||||
| Full Title: Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system releasing BAY 1007626,... | |||||||||||||
| Medical condition: Contraception | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) GB (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-020181-21 | Sponsor Protocol Number: BAY86-5028/13362 | Start Date*: 2011-01-13 | |||||||||||
| Sponsor Name:Bayer HealthCare AG | |||||||||||||
| Full Title: Multicenter, randomized, open-label, parallel-group study to evaluate user satisfaction with and tolerability of the low-dose levonorgestrel (LNG) intrauterine delivery system (IUS) with 12 µg LNG/... | |||||||||||||
| Medical condition: The aim of the present study is to examine the overall satisfaction with and tolerability of LCS12 compared with a standard combined oral contraceptive (COC; Yasmin; 30 µg ethinyl estradiol and 3 m... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: AT (Completed) BE (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-004978-25 | Sponsor Protocol Number: 300 | Start Date*: 2006-09-06 | |||||||||||
| Sponsor Name:International Committee for Contraception Research of the Population Council | |||||||||||||
| Full Title: A multicenter, open-label study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of 150 µg of Nestorone(R) and 15 µg of ethinyl estradiol (150/15 NE... | |||||||||||||
| Medical condition: As the trial is intended to investigate a new contraceptive medicinal product, the study subjects included are not characterized by a specific medical condition. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: SE (Ongoing) FI (Completed) HU (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-002065-37 | Sponsor Protocol Number: BAY86-5028 / 14371 | Start Date*: 2011-09-12 | |||||||||||
| Sponsor Name:Bayer HealthCare AG | |||||||||||||
| Full Title: Multi-center, single-arm study to assess the safety, efficacy, discontinuation rate and pharmacokinetics of the low-dose levonorgestrel intrauterine contraceptive system (LCS12) in post-menarcheal ... | |||||||||||||
| Medical condition: Contraception | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18 | Gender: Female | ||||||||||||
| Trial protocol: SE (Completed) FI (Completed) NL (Completed) AT (Completed) BE (Completed) DE (Completed) DK (Completed) NO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
| Sponsor Name:IVI Madrid | ||
| Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
| Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005331-14 | Sponsor Protocol Number: 1411-MAD-079-CB | Start Date*: 2015-08-19 |
| Sponsor Name:IVI Madrid | ||
| Full Title: A prospective randomized trial to analyze the effect of the gonadotropin administered during controlled ovarian stimulation on embryo kinetics of development | ||
| Medical condition: The study is proposed to analyze the effect of three types of gonadotropin on embryo quality and kinetics of development in women undergoing an assisted reporduction treatment | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002214-77 | Sponsor Protocol Number: 1504-MAD-024-AR | Start Date*: 2016-05-05 |
| Sponsor Name:IVI Madrid | ||
| Full Title: Prospective randomized clinical trial to test the efficacy of a biosimilar recombinant FSH (Bemfola) vs. urinary FSH (Fostipur) in an oocyte donation program | ||
| Medical condition: The proposed study is to determine the efficacy of a recombinant FSH biosimilar vs. urinary FSH in oocyte donation program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005099-27 | Sponsor Protocol Number: IIBSP-FOS-2014-67 | Start Date*: 2015-05-18 |
| Sponsor Name:Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau | ||
| Full Title: randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP (Menopur) in patients with polycystic ovary ander a FIV/ICSI cicle. | ||
| Medical condition: women with polycystic ovary under a cicle of FIV/ICSI. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005660-42 | Sponsor Protocol Number: IIBSP-FOS-2016-01 | Start Date*: 2016-03-31 |
| Sponsor Name:Institut de Recerca HSCSP | ||
| Full Title: Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in patients with polycystic ovary under a FIV/ICSI cicle. | ||
| Medical condition: Women with polycystic ovary under a cicle of FIV/ICSI. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-001069-35 | Sponsor Protocol Number: IIBSP-EDA-2020-18 | Start Date*: 2021-07-06 |
| Sponsor Name:Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau | ||
| Full Title: Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study. | ||
| Medical condition: Cumulative live-birth rate. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000335-28 | Sponsor Protocol Number: 25198 | Start Date*: 2004-10-19 | |||||||||||
| Sponsor Name:Serono International SA | |||||||||||||
| Full Title: A phase IIIB/IV, open label study to assess the efficacy and safety of a pre-defined, fixed dose of Gonal-f® (Filled-by-Mass in a Prefilled Pen) based on subject baseline characteristics, for ovari... | |||||||||||||
| Medical condition: Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: SE (Completed) AT (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-003556-20 | Sponsor Protocol Number: 1806-LIS-044-SD | Start Date*: 2019-06-17 |
| Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDADE - CLÍNICA DE REPRODUÇÃO ASSISTIDA, LDA | ||
| Full Title: How do different ovarian stimulation protocols affect endometrial receptivity during a fresh in vitro fertilization attempt? | ||
| Medical condition: Women with a clinical indication to undergo Assisted Reproductive Technologies for infertility with a predicted normal response to Ovarian Stimulation and planned for a single blastocyst transfer | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: PT (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
